Sumitomo Pharma America, Inc.

This study tests a new drug called SMP-3124LP, which is a standard cancer drug wrapped in a fatty bubble (liposome) to help it work better. It is for adults with advanced solid tumors that have not responded to other treatments. The trial has two parts: first, finding a safe dose…

This study tests a new oral drug called enzomenib (DSP-5336) in people with acute leukemia and certain other blood cancers that have not responded to standard treatments. The trial has two phases: first, finding the safest dose, and then checking how well it works alone or combin…

This study tests a new treatment called DSP-1083, which involves implanting cells into the brain to help control Parkinson's disease symptoms. About 25 people with Parkinson's will either get the real implant or a sham surgery to see if it's safe and works. The goal is to improve…

This study tests an experimental pill called nuvisertib for people with myelofibrosis, a rare bone marrow disorder. It is for patients whose disease is moderate to high risk and who have not responded well to standard treatments. The goal is to see if the drug is safe and can shr…

This study tests a one-time injection of retinal cells made from stem cells (DSP-3077) into the eye of 12 adults with retinitis pigmentosa, a genetic condition that causes gradual vision loss. The main goal is to see if the treatment is safe and tolerable. Participants are groupe…